The results showed that TUG1 overexpression can increase the mortality of DHA treated glioma cells, which can be reversed by MAZ overexpression, confirming the resistant mechanism by this pathway (Figures 6(c) and 6(d)). The gene discussed is TUG1; the disease is central nervous system cancer.